When is a patient considered hypertensive?

When is a Patient Labeled as Hypertensive?

A patient is labeled as hypertensive when office blood pressure readings average ≥140/90 mmHg across multiple visits, with the specific diagnostic pathway depending on the presence of target organ damage, diabetes, or chronic kidney disease.

Diagnostic Thresholds Based on Patient Risk Profile

The diagnosis of hypertension follows a structured, visit-based approach that varies according to cardiovascular risk:

Visit 1: Initial Assessment

• If BP ≥140/90 mmHg at initial visit, take at least 2 additional readings during the same visit using a validated device
• Discard the first reading and average the latter two 1
• Immediate diagnosis: If BP ≥180/110 mmHg at visit 1, hypertension is diagnosed immediately 1, 2

Visit 2: Risk-Stratified Diagnosis (within 1 month)

High-Risk Patients (with macrovascular target organ damage, diabetes mellitus, or chronic kidney disease with GFR <60 mL/min/1.73 m²):

• Diagnosed as hypertensive if BP ≥140/90 mmHg 1, 2

Lower-Risk Patients (without the above conditions):

• Diagnosed immediately if BP ≥180/110 mmHg 1, 2
• If BP is lower, require further evaluation using one of three approaches:

Three Diagnostic Pathways for Lower-Risk Patients

1. Office Blood Pressure Monitoring (OBPM)

• Diagnosed as hypertensive if:
  • SBP ≥160 mmHg or DBP ≥100 mmHg averaged across first 3 visits, OR
  • SBP ≥140 mmHg or DBP ≥90 mmHg averaged across 5 visits 2

2. Ambulatory Blood Pressure Monitoring (ABPM) - Preferred Method

• Diagnosed as hypertensive if:
  • Mean awake SBP ≥135 mmHg or DBP ≥85 mmHg, OR
  • Mean 24-hour SBP ≥130 mmHg or DBP ≥80 mmHg 1, 2
• ABPM is the recommended out-of-office measurement method 1

3. Home Blood Pressure Monitoring (HBPM)

• Diagnosed as hypertensive if:
  • Average SBP ≥135 mmHg or DBP ≥85 mmHg 1, 2
• Use duplicate measures, morning and evening, for 7 days (discard first day) 1
• If home BP <135/85 mmHg, perform 24-hour ABPM to confirm white coat hypertension before withholding treatment 2

Critical Nuances and Pitfalls

White Coat Hypertension: The 2018 Canadian guidelines emphasize that if out-of-office BP average is not elevated, white coat hypertension should be diagnosed and pharmacologic treatment should NOT be instituted 1. This is a common pitfall—treating elevated office readings without confirming with out-of-office measurements in lower-risk patients.

Automated Office BP (AOBP): The 2018 guidelines introduced different thresholds for AOBP measurements. If visit 1 mean AOBP SBP is 135-179 mmHg and/or DBP is 85-109 mmHg (versus 140-179/90-109 mmHg for non-AOBP), out-of-office measurements should be performed 1. This reflects the lower readings typically obtained with automated devices.

Hypertensive Emergency: Patients demonstrating features of hypertensive urgency or emergency should be diagnosed as hypertensive immediately and require urgent management, regardless of the usual diagnostic algorithm 2, 3.

Evidence Strength and Guideline Evolution

The most recent high-quality guideline is the 2018 Hypertension Canada guideline 1, which refined the 2013 recommendations 2 by introducing AOBP-specific thresholds and emphasizing out-of-office BP monitoring before visit 2 for intermediate BP elevations. The 2020 International Society of Hypertension guidelines 4 and 2024 ESC guidelines 5 align with these thresholds (≥140/90 mmHg for office BP, ≥135/85 mmHg for home BP, ≥130/80 mmHg for 24-hour ambulatory BP).

The key algorithmic decision point is whether the patient has target organ damage, diabetes, or CKD—this determines whether diagnosis can be made at visit 2 with BP ≥140/90 mmHg or requires either higher thresholds (≥180/110 mmHg) or additional visits/out-of-office monitoring.